icon-    folder.gif   Conference Reports for NATAP  
 
  (APASL) 25th Conference of the Asian Pacific
Association for the Study of the Liver
Feb 20-24 2016, Tokyo, Japan

Back grey_arrow_rt.gif
 
 
 
SLAM C study Sofosbuvir and Ledipasvir versus Sofosbuvir and Simeprevir combination therapy in the management of acute hepatitis C: A randomized open label prospective clinical pilot study. (drug rehabs in NYC]
 
 
  Reported by Jules Levin
APASL
 
25th Conference of the Asian Pacific Association for the Study of the Liver Feb 2024, Tokyo, Japan
 
AASLD 2015
 
Drug-Drug Interaction Studies Between Hepatitis C Virus Antivirals Sofosbuvir and Velpatasvir (GS-5816) and HIV Antiretoviral Therapies - (12/08/15)
 
SOFOSBUVIR IN THE TREATMENT OF ACUTE HCV INFECTION IN HIV-INFECTED MEN - (12/04/15)
 
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals: SWIFT-C....Harvoni 8 weeks enrolling - (12/04/15)
 
P. Patrick Basu, MD, MRCP, AGAF1,2, Niraj James Shah, MD3, Sakina Farhat MD2 , Nimy John, MD2, Leena Kavali, MD2, Elona Shehi, MD2, Mark M Aloysius MD, PhD4, Robert S Brown Jr, MD, MPH5
1 College of Physicians and Surgeons, Columbia University, New York, NY; 2 King's County Hospital Medical Center, NY; 3 Liver Transplant Center, University of North Carolina School of Medicine, Carolinas Medical Center, Charlotte, NC; 4James J. Peters VA Medical Center, Icahn School of Medicine at Mount Sinai, NY; 5Weill Cornell Medical College, New York, NY

HCV1

HCV2

HCV3

HCV4

HCV5